21 research outputs found

    Supporting Clean Energy in the ASEAN: Policy Opportunities from Sustainable Aviation Fuels Initiatives in Indonesia and Malaysia

    Get PDF
    Sustainable aviation fuels is a strategic long-term solution for zero-carbon aviation industry by 2050, thus underscoring the need to accelerate the deployment through reforms in the relevant key areas. Aligned to the agenda, this paper aims to study the policy opportunities for drop-in sustainable aviation fuel (SAF) deployment in the ASEAN by considering the initiatives undertaken. by Indonesia and Malaysia. Four areas are used as coding framework to assess the current status, challenges, and policy opportunities, namely (1) policy, strategy, and reforms; (2) standards and certification system; (3) economic instruments; and (4) international integration. First, the current status and challenges within each country is assessed. Indonesia has shown a more command-and-control approach with an upfront SAF blending mandate. However, it needs to be supported by several compliance measures. Malaysia, on the other hand, has conducted country assessments but no SAF-specific policy has been issued yet. Both countries still lack the economic instruments, while international integration is still relatively under-explored with only limited inter-regional partnerships. As the biggest palm-oil producing countries, Indonesia and Malaysia possess enormous potentials to lead the region in deploying SAF, thus more initiatives are urged

    In-vitro Antibacterial Activities of Selected Traditional Plants

    No full text
    The present research work was focused on the antibacterial activity of medicinal plants (Aegle marmelos, Citrus aurantifolia, Piper sarmentosum, Sesbania grandiflora, Carthamus tinctorius, Piper longum, Morus alba, Green tea and Oolong tea). Extracts were examined using water, methanol and ethanol as solvents and tested against six human pathogens (Staphylococcus aureus DMST4212, Bacillus cereus DMST5040, Staphylococcus epidermidis DMST518, Escherichia coli ATCC25922, Methicillin-resistant Staphylococcus aureus (MRSA) DMST20625 and Pseudomonas aeruginosa DMST4739) using the agar well diffusion method. The five day methanol extracts of green tea showed significant activity against MRSA and S. aureus of around 28.3 mm. The five day methanol extracts of A. marmelos exhibited the highest antibacterial activity against S. epidermidis (29.7 mm) and lowest in E. coli (no inhibition zone). The drop plate technique found that three day ethanol and three day methanol extracts of P. longum; water, three day and five day methanol and three day and five day ethanol extracts of green tea and oolong tea; three day and five day methanol and three day and five day ethanol extracts of C. aurantifolia; and three day ethanol extract of S. grandiflora had no growth for all six human pathogens. The results demonstrated that this plant has strong antibacterial potential against all tested bacteria

    Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells

    No full text
    Intravenous infusion of mesenchymal stromal cells (MSCs) is thought to be a viable treatment for numerous disorders. Although the intrinsic immunosuppressive ability of MSCs has been credited for this therapeutic effect, their exact impact on endogenous tissue-resident cells following delivery has not been clearly characterized. Moreover, multiple studies have reported pulmonary sequestration of MSCs upon intravenous delivery. Despite substantial efforts to improve MSC homing, it remains unclear whether MSC migration to the site of injury is necessary to achieve a therapeutic effect. Using a murine excisional wound healing model, we offer an explanation of how sequestered MSCs improve healing through their systemic impact on macrophage subpopulations. We demonstrate that infusion of MSCs leads to pulmonary entrapment followed by rapid clearance, but also significantly accelerates wound closure. Using single-cell RNA sequencing of the wound, we show that following MSC delivery, innate immune cells, particularly macrophages, exhibit distinctive transcriptional changes. We identify the appearance of a pro-angiogenic CD9(+) macrophage subpopulation, whose induction is mediated by several proteins secreted by MSCs, including COL6A1, PRG4, and TGFB3. Our findings suggest that MSCs do not need to act locally to induce broad changes in the immune system and ultimately treat disease

    Supplemental Material for Forche et al., 2018

    No full text
    Figure S1 provides detailed overview of experiment. Supplemental figure 2 shows <i>GAL1</i> LOH frequencies <br>Supplemental figure 3 shows examples of single and double aneuploidies<br>Supplemental figure 4 shows frequency of whole Chr LOH<br>Supplemental figure 5 shows a map with LOH breaks along Chr1<br>Supplemental figure 6 shows frequency of recurrent missegregation events <br><div>Table S1 contains strains, primers and plasmids for construction of strain YJB9318<br>Table S2 contains overview of ploidy and colony phenotypes<br>Table S3 provides summary of all detected events<br>Table S4 shows position and frequency of break regions<br>Table S5 shows frequency of recurrent missegregation events<br>Table S6 shows summary of multiple event frequency by mouse</div><div>File S1 is the custom R script<br></div

    Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells

    No full text
    The original version of this Article omitted the following from the Acknowledgements: “G.B. acknowledges the support from the Cancer Prevention and Research Institute of Texas (RR140081 and RR170721).”This has now been corrected in both the PDF and HTML versions of the Article

    Gene correction for SCID-X1 in long-term hematopoietic stem cells

    No full text
    Gene correction in hematopoietic stem cells could be a powerful way to treat monogenic diseases of the blood and immune system. Here the authors develop a strategy using CRISPR-Cas9 and an aAdeno-Associated vVirus(AAV)-delivered IL2RG cDNA to correct X-linked sSevere Ccombined iImmunodeficiency (SCID-X1) with a high success rate
    corecore